Trial Profile
A retrospective study evaluating the utility of Ceftaroline (CF) for the treatment of methicillin resistant staphylococcus aureus (MRSA) bacteremia, endocarditis and other deep seated infections.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Ceftaroline fosamil (Primary)
- Indications Endocarditis; Methicillin-resistant Staphylococcus aureus infections
- Focus Therapeutic Use
- 19 Dec 2015 New trial record